AIM ImmunoTech to Present at the Q1 Virtual Investor Summit on March 24th
OCALA, Fla., March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – AIM ImmunoTech Inc. (NYSE American: AIM) today announced that Thomas K. Equels, Chief Executive Officer of AIM ImmunoTech, will be presenting at the Q1 Virtual Investor Summit. Event Q1 Investor Summit Date March 23-25th, 2021 Presentation March 24th @ 3:00 PM ET Location https://zoom.us/webinar/register/WN_y7LDL2ROTQqvz3iOVkINMw About The Investor SummitThe…